Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_assertion type Assertion NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_head.
- NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_assertion wasGeneratedBy ECO_0000203 NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_provenance.
- NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_assertion wasDerivedFrom befree-20140225 NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_provenance.
- NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_assertion SIO_000772 19864236 NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_provenance.
- NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_assertion evidence source_evidence_literature NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_provenance.
- NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_assertion description "[Our results from a large series of Chinese patients with breast cancer support that the ASCO/CAP 30% criterion may offer better results for assessing HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887301.RAM0cm_ue3mLptTTnCC0comzeLmmdRWI8BoViGXOB9qg8130_provenance.